<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.pharmanation.in/news/nppa-cancer-medicine-price-cuts-november-2026-hindinppa-cancer-medicine-price-cuts/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-29T01:48:46.243Z</news:publication_date>
      <news:title>NPPA ने घटाईं 543 कैंसर दवा फॉर्मूलेशन की कीमतें, 9 नवंबर से नई दरें लागू</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/nppa-cancer-medicine-price-cuts-november-2026/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-28T03:22:15.006Z</news:publication_date>
      <news:title>NPPA Cuts Prices of 543 Cancer Medicine Formulations from November 9</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/cdsco-cancels-fatx-solution-registration-misleading-claims/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-27T16:05:14.602Z</news:publication_date>
      <news:title>CDSCO Cancels FatX Solution Registration Over Misleading Claims: Key Lessons for India’s Cosmetic Industry</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/cdsco-approves-zytorvi-toripalimab-oesophageal-cancer-india/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-27T15:05:46.974Z</news:publication_date>
      <news:title>CDSCO Approves Zytorvi for Advanced Oesophageal Cancer in India</news:title>
    </news:news>
  </url>
</urlset>
